Clinical Trials Directory

Trials / Completed

CompletedNCT02580903

Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms

Pulmonary Hypertension in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms; an Observational Prospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Odense University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis. All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association. All patients will be followed up for a total of five years to identify prognosis.

Conditions

Interventions

TypeNameDescription
RADIATIONRadiologyOnly a small subsample will require CT and right heart catherisation

Timeline

Start date
2015-02-01
Primary completion
2018-02-01
Completion
2020-02-01
First posted
2015-10-20
Last updated
2020-09-16

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02580903. Inclusion in this directory is not an endorsement.